Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model

Clinical and Experimental Metastasis

Volumn 22, Issue 3, 2005, Pages 237-246

  Mendes, Odete ^a   Kim, Hun Taek ^a   Stoica, George ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Animal model; Brain metastasis; Breast cancer; MMP2; MMP3; MMP9

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ADENOCARCINOMA; ANIMALS; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGOPEPTIDES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 24744464071     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-8115-6     Document Type: Article

References (49)

1. Stark AM, Tongers K, Maass N et al. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 2004; Dec 8 (E-Pub):1432-35
2. D Rusciano MM Burger 1992 Why do cancer cells metastasize into particular organs? Bioessays 14 3 185 94
3. DG Hall G Stoica 1994 Characterization of brain and bone-metastasizing clones selected from an ethylnitrosurea-induced rat mammary carcinoma Clin Exp Metastasis 12 4 283 95
4. Nishizuka A I et al. Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray Breast Cancer. 2002; 9(1): 26-32.
5. S Leppa T Saarto L Vehmanen 2004 A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma Clin Cancer Res 10 3 1057 63
6. WG Stetler-Stevenson S Aznavoorian LA Liotta 1993 Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9 541 73
7. N Levicar RK Nuttall TT Lah 2003 Proteases in brain tumor progression Acta Neurochir 145 825 38
8. DG Menter JL Herrmann GL Nicolson 1995 The role of trophic factors and autocrine/paracrine growth factors in brain metastasis Clin Exp Metastasis 13 2 67 88
9. T Fujimaki JE Price D Fan CD Bucana K Itoh T Kirino IJ Fidler 1996 Selective growth of human melanoma cells in the brain parenchyma of nude mice Melanoma Res 6 5 363 71
10. 109-Tyr bond Cancer Res 63 6758 62
11. G Rocca I Pucci-Minafra A Marrazo 2004 Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera Br J Cancer 90 1414 21
12. V Djonov N Cresto DM Aebersold 2002 Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer Int J Oncol 21 1 25 30
13. A Talvensaari-Mattila P Paakko G Blanco-Sequeiros 2001 Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy Breast Cancer Res Treat 65 1 55 61
14. MJ Duffy TM Maguire A Hill 2000 Metalloproteinases: role in breast carcinogenesis, invasion and metastasis Breast Cancer Res 2 4 252 57
15. RO Hynes 2003 Metastatic potential: generic predisposition of the primary tumor or rare metastatic variants-or both? Cell 113 821 23
16. M Balduyck F Zerimech V Gouyer 2000 Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro Clin Exp Metastasis 18 2 171 78
17. A Lebeau AG Nerlich U Sauer 1999 Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas Anticancer Res 19 5B 4257 64
18. KJ Heppner LM Matrisian RA Jensen 1996 Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response Am J Pathol 149 1 273 8
19. T Yoneda 2000 Cellular and molecular basis of preferential metastasis of breast cancer to bone J Orthop Sci 5 75 81
20. T Oshiba C Miyaura M Inada 2003 Role of RANKL-induced osteoclast formation and MMP-dependent matrix degerdation in bone destruction by breast cancer metastasis British J Cancer 88 1318 1326
21. KA Scott H Holdsworth FR Balkwill 2000 Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model Br J Cancer 83 11 1538 43
22. AM Tester M Waltham SJ Oh 2004 Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice Cancer Res 64 2 652 8
23. S Nozaki S Sissons DS Chien GW Sledge Jr 2003 Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model Clin Exp Metastasis 20 5 407 12
24. SJ Lee H Sakurai K Oshima SH Kim I Saiki 2003 Jul Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b Eur J Cancer 39 11 1632 41
25. S Saad LJ Bendall A James 2000 Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts Breast Cancer Res Treat 63 2 105 15
26. MA Lafleur AM Tester EW Thompson 2003 Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism FEBS Lett 553 3 457 63
27. Yan SJ, Blomme EAG In situ zymography: A molecular pathology technique to localize endogenous protease activity in tissue sections Veterinary Pathology 2003; 40: 227-36
28. P Lee J Hwang G Murphy M Io 2000 Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells Endocrinology 141 10 3764 73
29. W Lu X Zhou B Hong J Liu Z Yue 2004 Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP2 and PTEN gene Cancer Lett 214 205 13
30. RE Chapman AA Scott AM Deschamps AS Lowry RE Stroud JS Ikonomidis FG Spinale 2003 Matrix metalloproteinase abundance in human myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition J Mol Cell Cardiol 35 5 539 48
31. AL Chancey GL Brower JT Peterson JS Janicki 2002 Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload Circulation 105 16 1983 88
32. A Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated invasion Genes &Development 1999; 13: 35-48
33. EM Muir KH Adcock DA Morgesnten 2002 Matrix Metalloproteinases and their inhibitors are produced by overlapping populations of brain astrocytes Mol Brain Res 100 103 17
34. M Wang YE Liu J Greene 1997 Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4 Oncogene 14 23 2767 74
35. JL Jones P Glynn RA Walker 1999 Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas J Pathol 189 2 161 8
36. S Caudroy M Polette JM Tournier 1999 Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions J Histochem Cytochem 47 12 1575 80
37. JE Bartsch ED Staren HE Appert 2003 Matrix metalloproteinase expression in breast cancer J Surg Res 110 2 383 92
38. O Brummer S Athar L Riethdorf 1999 Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study Virchows Arch 435 6 566 73
39. LA Rudolph-Owen LM Matrisian 1998 Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland J Mammary Gland Biol Neoplasia 3 2 177 89
40. MP Shekhar J Werdell SJ Santner 2001 Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression Cancer Res 61 4 1320 26
41. AS Mellick D Blackmore SR Weinstein 2003 An Assessment of MMP and TIMP Gene Expression in Cell Lines and Stroma-Tumour Differences in Microdissected Breast Cancer Biopsies Tumour Biol 24 5 258 62
42. A Nabeshima 2002 K Matrix metalloproteinases in tumor invasion: Role for cell migration Pathol Int 52 255 64
43. K Arai S Lee EH Loo 2003 Essential role for ERK mitogen-activated protein kinase in matrix mettaloproteinase-9 regulation in rat cortical astrocytes Glia 43 254 64
44. GA Rosenberg LA Cunningham J Wallace 2001 Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglial in cell cultures Brain Res 823 104 12
45. S Rivera C Ogier J Jourquin 2002 Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia Eur J Neurosci 15 19 32
46. DM Le A Besson DK Fogg 2003 Exploitation of astrocytes by glioma cells to facilitate invasivemess: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade The J of Neurosci 23 10 4034 43
47. A Sierra JE Price M Garcia-Ramirez 1997 Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells Lab Invest 77 4 357 68
48. DM Le A Besson DK Fogg 2003 Exploitation of astrocytes by glioma cells to facilitate invasivemess: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade The J of Neurosci 23 10 4034 43
49. PM O'Brien DF Ortwine AG Pavlovsky JA Picard DR Sliskovic BD Roth RD Dyer LL Johnson CF Man H Hallak 2000 Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors J Med Chem 43 2 156 66